Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2025)

Spero Therapeutics' Asset Utilization Ratio history spans 9 years, with the latest figure at 1.14 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 486.84% year-over-year to 1.14; the TTM value through Dec 2025 reached 1.14, up 486.84%, while the annual FY2025 figure was 0.52, 20593.05% up from the prior year.
  • Asset Utilization Ratio reached 1.14 in Q4 2025 per SPRO's latest filing, up from 0.4 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.14 in Q4 2025 to a low of 0.1 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.29, with a median of 0.22 recorded in 2024.
  • The largest YoY upside for Asset Utilization Ratio was 1736.93% in 2022 against a maximum downside of 545.91% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then surged by 1736.93% to 0.24 in 2022, then soared by 174.21% to 0.66 in 2023, then plummeted by 70.66% to 0.19 in 2024, then skyrocketed by 486.84% to 1.14 in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Asset Utilization Ratio are 1.14 (Q4 2025), 0.4 (Q3 2025), and 0.45 (Q2 2025).